‘Testosterone made me feel like hot s**t – at first’ – The i Paper
Initial euphoria from testosterone therapy often plateaus as the body adjusts, highlighting the need for realistic patient expectations.
-
-
Q&A: Should you trust trending peptide injections? – news.virginia.edu
Virginia health officials urge caution as peptide injections trend on social media despite limited safety data and rising adverse events.
-
APhA2026: GLP-1 Therapies Are Rewriting the Rules of Metabolic Disease – Pharmacy Times
GLP-1 receptor agonists are transforming metabolic disease treatment with unprecedented cardiovascular and weight loss benefits.
-
Why Pennsylvania’s women are struggling to find estrogen patches for menopause hormone therapy – WHYY
Ongoing shortages of estrogen patches are forcing menopausal women to switch treatments or go without symptom relief.
-
Dual-Agonist Incretin Therapy Outshines GLP-1 Agonist in Broad Cardiorenal Outcomes – consultqd.clevelandclinic.org
Tirzepatide shows 30% lower cardiorenal risk versus semaglutide in large real-world study of type 2 diabetes patients.
-
Exosome Therapy Shows Promise for Severe Peripheral Nerve Injuries – University of Miami
Engineered exosomes show 60% improvement in motor recovery for severe nerve injuries in preclinical study.
-
Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease – Cleveland Clinic Newsroom
Real-world data shows tirzepatide reduced heart failure and kidney disease risk by over 20% versus dulaglutide in type 2 diabetes patients.
-
Phase 3b data presented at AAD Annual Meeting show Lilly’s Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity – PR Newswire
Phase 3 data shows Taltz plus Zepbound improved arthritis symptoms and achieved 15% weight loss in psoriatic arthritis patients.
-
Menopause hormone therapy treatments would be covered by health insurance under Ohio bill – Ohio Capital Journal
Ohio legislation would require insurance to cover menopause hormone therapy and eliminate prior authorization barriers.
-
‘I have the energy of a 21-year-old’: The peptide wellness boom taking over your social media – nzherald.co.nz
Social media influencers are fueling explosive growth in peptide therapies, raising concerns about safety and regulation.
